4//SEC Filing
MALCOLM JAN 4
Accession 0001562180-25-005511
CIK 0001082554other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 6:10 AM ET
Size
16.0 KB
Accession
0001562180-25-005511
Insider Transaction Report
Form 4
MALCOLM JAN
Director
Transactions
- Exercise/Conversion
Common Stock
2025-06-26+630→ 630 total - Award
Stock Options
2025-07-24+1,830→ 1,830 totalExercise: $306.41From: 2026-07-09Exp: 2035-07-24→ Common Stock (1,830 underlying) - Exercise/Conversion
Common Stock
2025-07-25+590→ 1,220 total - Exercise/Conversion
Restricted Stock Unit
2025-06-26−630→ 0 totalExercise: $0.00From: 2025-06-26→ Common Stock (630 underlying) - Award
Restricted Stock Unit
2025-07-24+650→ 650 totalExercise: $0.00From: 2026-07-09→ Common Stock (650 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-07-25−590→ 0 totalExercise: $0.00From: 2025-07-25→ Common Stock (590 underlying)
Footnotes (5)
- [F1]Shares received upon vesting of restricted stock units on June 26, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
- [F2]Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
- [F3]Not applicable as restricted stock units do not have an expiration date.
- [F4]Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- [F5]Annual non-employee director award.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0002028640
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 6:10 AM ET
- Size
- 16.0 KB